Aug 2026· HYPERTENSION· Vol 83, pp. e27333 - e27333· 0 citations· 17 references
Medicine
TL;DR
IDH in young adulthood represents an early marker of elevated CVD risk and a precursor to more adverse hypertension subtypes and underscores the importance of early recognition, ongoing BP monitoring, and guideline-concordant pharmacologic treatment when indicated among young adults with IDH to reduce long-term CVD risk.
Abstract
Background: Whether isolated diastolic hypertension (IDH) in young adults represents a benign, age-specific phenotype or confers increased cardiovascular disease (CVD) risk remains uncertain. We assessed the associations between hypertension subtypes - IDH, isolated systolic hypertension (ISH), and systolic-diastolic hypertension (SDH) - with atherosclerotic CVD (ASCVD) and heart failure (HF), and characterized longitudinal transitions in hypertension subtypes from young adulthood into later life. Methods: Adults aged ≥18 years without CVD were included from four US cohorts. Hypertension subtypes were defined using BP thresholds of ≥130/80 mm Hg. Cox proportional hazard models estimated the associations between hypertension subtypes with ASCVD and HF. Results: Among 23,957 participants (mean age 44.5 years, 42.5% young adults aged 18–39 years, 45.1% male), 2,320 ASCVD and 1,243 HF events occurred over a median follow-up of 17.2 years. In young adults, the adjusted hazard ratios (HR [95% CI]) for ASCVD were 1.36 (1.11–1.68) for IDH, 1.54 (1.02–2.32) for ISH, and 1.84 (1.46–2.32) for SDH, compared to normotension. Corresponding HRs for HF were 1.69 (1.24–2.31) for IDH, 1.92 (1.09–3.40) for ISH, and 1.69 (1.17–2.43) for SDH. Associations were consistent among adults aged ≥40 years. In young adults with IDH, 29.8% remained with IDH while 36.5% progressed to SDH later in life. Conclusions: IDH in young adulthood represents an early marker of elevated CVD risk and a precursor to more adverse hypertension subtypes. These findings underscore the importance of early recognition, ongoing BP monitoring, and guideline-concordant pharmacologic treatment when indicated among young adults with IDH to reduce long-term CVD risk.
BACKGROUND
Atherosclerosis may begin in early adulthood and remain clinically silent for decades before cardiovascular disease manifests. Although silent atherosclerosis is associated with cardiovascular events and death independent of traditional cardiovascular disease risk factors, its age- and sex-specific prevalenc...
H. Bundgaard, I. García-Lunar, K. F. Kofoed et al.· New England Journal of Medic...· 0 citations
Background Prediabetes is common among adults with hypertension, but its contribution to heart failure (HF) risk, particularly in the presence of subclinical myocardial abnormalities, remains uncertain. Objectives The objective of the study was to assess whether prediabetes combined with malignant left ventricular hype...
Arnaud D. Kaze, Stephen P. Juraschek, Jordana B. Cohen et al.· JACC: Advances· 0 citations
Abstract Background We evaluated baseline hypertension prevalence and control and risk of major adverse cardiovascular events (MACEs) among people with HIV in REPRIEVE who had low to moderate traditional cardiovascular disease (CVD) risk. Methods Hypertension at baseline was defined by (1) a preexisting diagnosis regar...
Risa M. Hoffman, Maya Watanabe, E. Martínez et al.· Open Forum Infectious Diseas...· 0 citations
AIMS
Chronic inflammation associates with prevalent and short-term incident hypertension. The aim of this study is to determine whether baseline high-sensitivity C-reactive protein (hsCRP) independently associates with incident hypertension over three decades in women.
METHODS
Normotensive Women's Health Study partic...
N. Adamstein, M. Moorthy, N. Cook et al.· European Journal of Preventi...· 1 citation
Background: High blood pressure (BP) in young adults is an underrecognised public health issue with potential long-term health consequences, including increased mortality risk. To examine the prevalence of prehypertension among US young adults and assess its association with all-cause and cardiovascular mortality. Meth...
M. Ying, Kunming Bao, Dongjun Bao et al.· Blood Pressure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.